Mangoceuticals, Inc. (MGRX) Insider Trading Activity

NASDAQ$0.3791
Market Cap
$4.35M
Sector
Healthcare
Industry
Medical—Healthcare Information Services
Rank in Sector
683 of 885
Rank in Industry
29 of 39

MGRX Insider Trading Activity

MGRX Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
0
Sells
$174,014
4
100

Related Transactions

JOHNSTON EUGENE MCFO
0
$0
3
$21,139
$-21,139
Hamilton Alex P.director
0
$0
1
$152,875
$-152,875

About Mangoceuticals, Inc.

Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

Insider Activity of Mangoceuticals, Inc.

Over the last 12 months, insiders at Mangoceuticals, Inc. have bought $0 and sold $174,014 worth of Mangoceuticals, Inc. stock.

On average, over the past 5 years, insiders at Mangoceuticals, Inc. have bought $275,000 and sold $106,924 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 275,000 shares for transaction amount of $275,000 was made by Cohen Jacob D. (Chief Executive Officer) on 2023‑04‑10.

List of Insider Buy and Sell Transactions, Mangoceuticals, Inc.

2025-12-15SaleJOHNSTON EUGENE MCFO
3,333
0.0295%
$1.17
$3,884
-43.75%
2025-12-09SaleJOHNSTON EUGENE MCFO
5,000
0.0435%
$1.20
$5,975
-45.70%
2025-12-05SaleJOHNSTON EUGENE MCFO
10,000
0.0897%
$1.13
$11,280
-38.68%
2025-11-19SaleHamilton Alex P.director
125,000
1.1702%
$1.22
$152,875
-37.90%
2024-06-26SaleHamilton Alex P.director
108,426
0.6961%
$0.32
$34,696
-46.46%
2024-06-25SaleHamilton Alex P.director
16,574
0.1031%
$0.31
$5,138
-43.64%
2023-04-10PurchaseCohen Jacob D.Chief Executive Officer
275,000
5.5173%
$1.00
$275,000
-4.39%
Total: 7
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
JOHNSTON EUGENE MCFO
120000
1.0493%
$45,600.0003
Hamilton Alex P.director
3334
0.0292%
$1,266.9203
Cohen Jacob D.Chief Executive Officer
8275000
72.3605%
$3.14M10
<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$1,197,867
27
63.73%
$603.35M
$171,033,572
24
220.69%
$2.63B
$1,129,324
21
20.33%
$102.18M
$10,866
12
-23.14%
$20.13M
$2,429,291
8
27.89%
$295.53M
$100,706
3
-58.80%
$48.22M
$258,661,156
2
42.09%
$6.94B
Mangoceuticals, Inc.
(MGRX)
$275,000
1
-4.39%
$4.35M

MGRX Institutional Investors: Active Positions

Increased Positions13+216.67%477,857+148.65%
Decreased Positions2-33.33%3,944-1.23%
New Positions9New113,804New
Sold Out Positions2Sold Out3,944Sold Out
Total Postitions17+183.33%795,386+147.42%

MGRX Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$164.001.28%192,004+9,391+5.14%2025-09-30
Geode Capital Management, Llc$75.000.59%87,974+61,476+232%2025-09-30
Ackerman Capital Advisors, Llc$29.000.23%34,50000%2025-09-30
Xtx Topco Ltd$24.000.19%28,514+28,514New2025-09-30
Northern Trust Corp$16.000.13%18,957+18,957New2025-09-30
Sunbelt Securities, Inc.$6.000.05%7,000+7,000New2025-09-30
Osaic Holdings, Inc.$2.000.02%2,88500%2025-09-30
Steward Partners Investment Advisory, Llc$2.000.01%2,09400%2025-09-30
Royal Bank Of Canada$0<0.01%451+451New2025-09-30
Bank Of America Corp /De/$0<0.01%176+13+7.97%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

No data is available at this moment.

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.